Eli Lilly and Company: Depression trials
The registry lists 17 Depression studies with Eli Lilly and Company as lead sponsor. 2 are open to participants now and 4 have results posted.
Phase 2 2Phase 3 6Phase 4 7No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruitingNCT07775300Phase 3
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruitingNCT07412756Phase 3
- Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2Results posted
- A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorCompletedNCT01185340Phase 3Results posted
- Early Versus Delayed Switch in Medication in Patients With Major Depressive DisorderCompletedNCT00810069Phase 4Results posted
- A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionCompletedNCT00666757Phase 4Results posted
- A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)CompletedNCT06524830Phase 2
- Major Depressive Disorder (MDD)CompletedNCT01662817
- Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US AdultsCompletedNCT00763724
- Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCompletedNCT00494377Phase 4
- Combination Therapy in Patients With DepressionCompletedNCT00485862Phase 4
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
- Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
- Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
- Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4